Drug Shortage Report for ONCOTICE
| Report ID | 63600 |
| Drug Identification Number | 02153513 |
| Brand name | ONCOTICE |
| Common or Proper name | Bacillus Calmette- Guérin (BCG), strain TICE powder for solution |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BACILLUS CALMETTE-GUERIN |
| Strength(s) | 800000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVESICAL |
| Packaging size | 1 vial |
| ATC code | L03AX |
| ATC description | IMMUNOSTIMULANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-10-19 |
| Actual start date | 2018-10-19 |
| Estimated end date | 2027-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-02-18 |
| Company comments | Manufacturing capacity constraints. Product is under allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v29 | 2022-02-18 | French | Compare |
| v28 | 2022-02-18 | English | Compare |
| v27 | 2021-09-29 | French | Compare |
| v26 | 2021-09-29 | English | Compare |
| v25 | 2021-06-23 | French | Compare |
| v24 | 2021-06-23 | English | Compare |
| v23 | 2020-09-01 | French | Compare |
| v22 | 2020-09-01 | English | Compare |
| v21 | 2019-08-07 | French | Compare |
| v20 | 2019-08-07 | English | Compare |
| v19 | 2019-06-27 | French | Compare |
| v18 | 2019-06-27 | English | Compare |
| v17 | 2019-05-23 | French | Compare |
| v16 | 2019-05-23 | English | Compare |
| v15 | 2019-05-16 | French | Compare |
| v14 | 2019-05-16 | English | Compare |
| v13 | 2019-03-08 | French | Compare |
| v12 | 2019-03-08 | English | Compare |
| v11 | 2019-03-08 | French | Compare |
| v10 | 2019-03-08 | French | Compare |